Literature DB >> 15319856

Human cytomegalovirus load in plasma and bronchoalveolar lavage fluid: a longitudinal study of lung transplant recipients.

Glen P Westall1, Alexandra Michaelides, Trevor J Williams, Greg I Snell, Thomas C Kotsimbos.   

Abstract

BACKGROUND: In lung transplant recipients (LTRs), the measurement of human cytomegalovirus (HCMV) load dynamics in the local environment of the lung allograft may offer distinct advantages over their assessment in the peripheral blood compartment.
METHODS: We compared HCMV load in paired bronchoalveolar lavage (BAL) and plasma samples in a prospective cohort of LTRs.
RESULTS: In all, 182 paired samples were collected from 41 LTRs. Qualitative findings were concordant for 79.7% of the paired samples (virus load detected or absent in 8.1% and 71.5% of paired samples, respectively). In 35 paired samples (20.3%), HCMV was detected in the BAL but not the plasma sample; the converse was not found for any of the paired samples. HCMV inclusions were histologically detected in the lungs of 8 patients on 9 occasions. HCMV was detected in both BAL and plasma samples on 7 of the 9 occasions and in only the BAL sample on 2 occasions. Application of a threshold virus load in BAL samples, to predict histologically proven HCMV infection, was associated with improved diagnostic sensitivity and specificity.
CONCLUSIONS: Quantification of HCMV in the lung allograft correlates with histological detection and, in addition, offers the potential to monitor subclinical viral replication in the lung allograft.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15319856     DOI: 10.1086/422327

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  21 in total

Review 1.  Management of cytomegalovirus infection in solid organ transplantation.

Authors:  Camille N Kotton
Journal:  Nat Rev Nephrol       Date:  2010-10-26       Impact factor: 28.314

2.  Detection of human cytomegalovirus in bronchoalveolar lavage fluid of lung transplant recipients reflects local virus replication and not contamination from the throat.

Authors:  Heidrun Kerschner; Peter Jaksch; Barbara Zweytick; Elisabeth Puchhammer-Stöckl
Journal:  J Clin Microbiol       Date:  2010-09-01       Impact factor: 5.948

3.  Epstein-Barr viral loads do not predict post-transplant lymphoproliferative disorder in pediatric lung transplant recipients: A multicenter prospective cohort study.

Authors:  Andrew Parrish; Matthew Fenchel; Gregory A Storch; Richard Buller; Sheila Mason; Nikki Williams; David Ikle; Carol Conrad; Albert Faro; Samuel Goldfarb; Don Hayes; Ernestina Melicoff-Portillo; Marc Schecter; Gary Visner; Stuart Sweet; Lara Danziger-Isakov
Journal:  Pediatr Transplant       Date:  2017-06-21

Review 4.  Lung transplantation: opportunities for research and clinical advancement.

Authors:  David S Wilkes; Thomas M Egan; Herbert Y Reynolds
Journal:  Am J Respir Crit Care Med       Date:  2005-07-14       Impact factor: 21.405

Review 5.  Viral infections in lung transplant recipients.

Authors:  Pali Dedhiya Shah; John F McDyer
Journal:  Semin Respir Crit Care Med       Date:  2010-03-30       Impact factor: 3.119

6.  Surveillance bronchoscopy in children during the first year after lung transplantation: Is it worth it?

Authors:  C Benden; O Harpur-Sinclair; A S Ranasinghe; J C Hartley; M J Elliott; P Aurora
Journal:  Thorax       Date:  2006-08-23       Impact factor: 9.139

7.  Relationship between cytomegalovirus DNA load in epithelial lining fluid and plasma of lung transplant recipients and analysis of coinfection with Epstein-Barr virus and human herpesvirus 6 in the lung compartment.

Authors:  Claudia C Bauer; Peter Jaksch; Stephan W Aberle; Heinrich Haber; Gyoergy Lang; Walter Klepetko; Hanns Hofmann; Elisabeth Puchhammer-Stöckl
Journal:  J Clin Microbiol       Date:  2006-12-06       Impact factor: 5.948

8.  Differential CMV-specific CD8+ effector T cell responses in the lung allograft predominate over the blood during human primary infection.

Authors:  Matthew R Pipeling; Erin E West; Christine M Osborne; Amanda B Whitlock; Lesia K Dropulic; Matthew H Willett; Michael Forman; Alexandra Valsamakis; Jonathan B Orens; David R Moller; Noah Lechtzin; Stephen A Migueles; Mark Connors; John F McDyer
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

9.  Comparison of automated nucleic acid extraction methods for the detection of cytomegalovirus DNA in fluids and tissues.

Authors:  Jesse J Waggoner; Benjamin A Pinsky
Journal:  PeerJ       Date:  2014-04-08       Impact factor: 2.984

10.  Molecular and Culture-Based Bronchoalveolar Lavage Fluid Testing for the Diagnosis of Cytomegalovirus Pneumonitis.

Authors:  Susanna K Tan; Elizabeth B Burgener; Jesse J Waggoner; Kiran Gajurel; Sarah Gonzalez; Sharon F Chen; Benjamin A Pinsky
Journal:  Open Forum Infect Dis       Date:  2016-02-10       Impact factor: 3.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.